• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸膜恶性间皮瘤活检与切除标本的核分级、坏死和组织学亚型比较:国际多机构分析。

Comparison of Nuclear Grade, Necrosis, and Histologic Subtype Between Biopsy and Resection in Pleural Malignant Mesothelioma: An International Multi-Institutional Analysis.

机构信息

Department of Pathology, University of Chicago, Chicago, IL, USA.

Department of Pathology and Lab Medicine, University of Wisconsin, Madison, WI, USA.

出版信息

Am J Clin Pathol. 2021 Nov 8;156(6):989-999. doi: 10.1093/ajcp/aqab054.

DOI:10.1093/ajcp/aqab054
PMID:33978147
Abstract

OBJECTIVES

Numerous studies on malignant mesothelioma (MM) highlight the prognostic importance of histologic subtype, nuclear grade, and necrosis. This study compares these parameters in paired biopsy and resection specimens of pleural MM.

METHODS

Histologic subtype, percentage of epithelioid morphology, nuclear grade, and the presence or absence of necrosis were compared in 429 paired biopsies and resection specimens of pleural MM from 19 institutions.

RESULTS

Histologic subtype was concordant in 81% of cases (κ = 0.58). When compared with resection specimens, epithelioid morphology at biopsy had a positive predictive value (PPV) of 78.9% and a negative predictive value (NPV) of 93.5%; sarcomatoid morphology showed high PPV (92.9%) and NPV (99.3%), and biphasic morphology PPV was 89.7% and NPV was 79.7%. Agreement of the percentage of epithelioid morphology was fair (κ = 0.27). Nuclear grade and necrosis were concordant in 75% (κ = 0.59) and 81% (κ = 0.53) of cases, respectively. Nuclear grade showed moderate (κ = 0.53) and substantial (κ = 0.67) agreement from patients with and without neoadjuvant therapy, respectively, and necrosis showed moderate (κ = 0.47 and κ = 0.60) agreement, respectively, in the same subsets of paired specimens.

CONCLUSIONS

Paired biopsy-resection specimens from pleural MM show overall moderate agreement in pathologic parameters. These findings may help guide postbiopsy management and triage of patients with MM.

摘要

目的

许多关于恶性间皮瘤(MM)的研究强调了组织学亚型、核分级和坏死的预后重要性。本研究比较了胸膜 MM 的配对活检和切除标本中的这些参数。

方法

比较了 19 个机构的 429 对胸膜 MM 的活检和切除标本中的组织学亚型、上皮样形态的百分比、核分级以及坏死的存在情况。

结果

81%的病例组织学亚型一致(κ=0.58)。与切除标本相比,活检时的上皮样形态具有较高的阳性预测值(PPV)(78.9%)和阴性预测值(NPV)(93.5%);肉瘤样形态的 PPV 较高(92.9%)和 NPV(99.3%),双相形态的 PPV 为 89.7%,NPV 为 79.7%。上皮样形态百分比的一致性为中等(κ=0.27)。核分级和坏死在 75%(κ=0.59)和 81%(κ=0.53)的病例中一致,分别。核分级在接受和未接受新辅助治疗的患者中分别具有中等(κ=0.53)和显著(κ=0.67)的一致性,坏死在相同的配对标本亚组中分别具有中等(κ=0.47 和 κ=0.60)的一致性。

结论

胸膜 MM 的配对活检-切除标本在病理参数方面总体上具有中等一致性。这些发现可能有助于指导活检后的管理和 MM 患者的分类。

相似文献

1
Comparison of Nuclear Grade, Necrosis, and Histologic Subtype Between Biopsy and Resection in Pleural Malignant Mesothelioma: An International Multi-Institutional Analysis.胸膜恶性间皮瘤活检与切除标本的核分级、坏死和组织学亚型比较:国际多机构分析。
Am J Clin Pathol. 2021 Nov 8;156(6):989-999. doi: 10.1093/ajcp/aqab054.
2
Accuracy of pleural biopsy for the diagnosis of histologic subtype of malignant pleural mesothelioma: Necropsy-based study of 134 cases.胸膜活检对恶性胸膜间皮瘤组织学亚型诊断的准确性:134 例尸检研究。
Tumori. 2022 Feb;108(1):26-32. doi: 10.1177/0300891620988354. Epub 2021 Mar 15.
3
Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study.核分级和坏死可预测恶性上皮样胸膜间皮瘤的预后:一项多机构研究。
Mod Pathol. 2018 Apr;31(4):598-606. doi: 10.1038/modpathol.2017.170. Epub 2018 Jan 12.
4
Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for cytopathology reporting.评估上皮样弥漫性胸膜间皮瘤细胞学标本中具有预后意义的形态学特征的可靠性及其对细胞病理学报告的影响。
Cancer Cytopathol. 2023 Aug;131(8):495-506. doi: 10.1002/cncy.22705. Epub 2023 May 1.
5
Pathology of Malignant Pleural Mesothelioma.恶性胸膜间皮瘤的病理学
Thorac Surg Clin. 2020 Nov;30(4):367-382. doi: 10.1016/j.thorsurg.2020.08.007.
6
Combined grade and nuclear grade are prognosis predictors of epithelioid malignant peritoneal mesothelioma: a multi-institutional retrospective study.联合分级和核分级是上皮样恶性腹膜间皮瘤的预后预测指标:一项多机构回顾性研究。
Virchows Arch. 2021 Nov;479(5):927-936. doi: 10.1007/s00428-021-03144-z. Epub 2021 Jun 24.
7
Interobserver variation in the assessment of the sarcomatoid and transitional components in biphasic mesotheliomas.评估双相性间皮瘤中肉瘤样和过渡型成分的观察者间变异性。
Mod Pathol. 2020 Feb;33(2):255-262. doi: 10.1038/s41379-019-0320-y. Epub 2019 Jul 4.
8
Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma.弥漫性恶性胸膜间皮瘤患者活检采样预测组织学的诊断价值。
Cancer. 2019 Dec 1;125(23):4164-4171. doi: 10.1002/cncr.32416. Epub 2019 Aug 7.
9
Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival.恶性胸膜间皮瘤组织学亚型的生存情况以及手术切除对总生存的影响。
Clin Lung Cancer. 2018 Nov;19(6):e901-e912. doi: 10.1016/j.cllc.2018.08.007. Epub 2018 Aug 29.
10
A Critical Assessment of Current Grading Schemes for Diffuse Pleural Mesothelioma With a Proposal for a Novel Mesothelioma Weighted Grading Scheme (MWGS).对当前弥漫性胸膜间皮瘤分级方案的批判性评估及一种新型间皮瘤加权分级方案(MWGS)的提议
Am J Surg Pathol. 2022 Jun 1;46(6):774-785. doi: 10.1097/PAS.0000000000001854. Epub 2021 Dec 15.

引用本文的文献

1
Pleural mesothelioma.胸膜间皮瘤
Nat Rev Dis Primers. 2025 Aug 7;11(1):56. doi: 10.1038/s41572-025-00640-3.
2
An Evaluation Into the Robustness of Grading of Pleural Mesothelioma Outside of Specialist Centres.对专科中心以外的胸膜间皮瘤分级稳健性的评估。
APMIS. 2025 Mar;133(3):e70006. doi: 10.1111/apm.70006.
3
Correlation of Histologic Features with Gene Alterations in Pleural Mesothelioma.胸膜间皮瘤组织学特征与基因改变的相关性
Mod Pathol. 2025 May;38(5):100706. doi: 10.1016/j.modpat.2025.100706. Epub 2025 Jan 7.
4
Immunotherapy for Treatment of Pleural Mesothelioma: Current and Emerging Therapeutic Strategies.胸膜间皮瘤的免疫治疗:当前和新兴的治疗策略。
Int J Mol Sci. 2024 Oct 9;25(19):10861. doi: 10.3390/ijms251910861.
5
Detailed clinical course of a patient with rapidly progressing sarcomatoid pleural mesothelioma without p16 deletion with systemic haematogenous metastasis to soft tissues.一名患有进展迅速的肉瘤样胸膜间皮瘤的患者的详细临床过程,该患者无 p16 缺失,伴有全身血源性软组织转移。
BMJ Case Rep. 2024 Feb 10;17(2):e257618. doi: 10.1136/bcr-2023-257618.
6
Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for cytopathology reporting.评估上皮样弥漫性胸膜间皮瘤细胞学标本中具有预后意义的形态学特征的可靠性及其对细胞病理学报告的影响。
Cancer Cytopathol. 2023 Aug;131(8):495-506. doi: 10.1002/cncy.22705. Epub 2023 May 1.
7
Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma.肿瘤免疫微环境在胸膜上皮样间皮瘤中的预后作用
Front Oncol. 2022 Jun 20;12:870352. doi: 10.3389/fonc.2022.870352. eCollection 2022.
8
Unusual Histology in Mesothelioma: A Report of Two Cases with a Brief Review.间皮瘤的罕见组织学表现:两例报告并简要综述
Diagnostics (Basel). 2022 Feb 1;12(2):371. doi: 10.3390/diagnostics12020371.
9
The Collagen Receptor uPARAP in Malignant Mesothelioma: A Potential Diagnostic Marker and Therapeutic Target.恶性间皮瘤中的胶原受体 uPARAP:一种潜在的诊断标志物和治疗靶点。
Int J Mol Sci. 2021 Oct 23;22(21):11452. doi: 10.3390/ijms222111452.
10
When the Diagnosis of Mesothelioma Challenges Textbooks and Guidelines.当间皮瘤的诊断对教科书和指南构成挑战时。
J Clin Med. 2021 May 30;10(11):2434. doi: 10.3390/jcm10112434.